1
|
Clua-Provost T, Durand A, Mu Z, Rastoin T, Fraunié J, Janzen E, Schutte H, Edgar JH, Seine G, Claverie A, Marie X, Robert C, Gil B, Cassabois G, Jacques V. Isotopic Control of the Boron-Vacancy Spin Defect in Hexagonal Boron Nitride. Phys Rev Lett 2023; 131:126901. [PMID: 37802939 DOI: 10.1103/physrevlett.131.126901] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Accepted: 08/26/2023] [Indexed: 10/08/2023]
Abstract
We report on electron spin resonance (ESR) spectroscopy of boron-vacancy (V_{B}^{-}) centers hosted in isotopically engineered hexagonal boron nitride (hBN) crystals. We first show that isotopic purification of hBN with ^{15}N yields a simplified and well-resolved hyperfine structure of V_{B}^{-} centers, while purification with ^{10}B leads to narrower ESR linewidths. These results establish isotopically purified h^{10}B^{15}N crystals as the optimal host material for future use of V_{B}^{-} spin defects in quantum technologies. Capitalizing on these findings, we then demonstrate optically induced polarization of ^{15}N nuclei in h^{10}B^{15}N, whose mechanism relies on electron-nuclear spin mixing in the V_{B}^{-} ground state. This work opens up new prospects for future developments of spin-based quantum sensors and simulators on a two-dimensional material platform.
Collapse
Affiliation(s)
- T Clua-Provost
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - A Durand
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - Z Mu
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - T Rastoin
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - J Fraunié
- Université de Toulouse, INSA-CNRS-UPS, LPCNO, 135 Avenue Rangueil, 31077 Toulouse, France
| | - E Janzen
- Tim Taylor Department of Chemical Engineering, Kansas State University, Manhattan, Kansas 66506, USA
| | - H Schutte
- Tim Taylor Department of Chemical Engineering, Kansas State University, Manhattan, Kansas 66506, USA
| | - J H Edgar
- Tim Taylor Department of Chemical Engineering, Kansas State University, Manhattan, Kansas 66506, USA
| | - G Seine
- CEMES-CNRS and Université de Toulouse, 29 rue J. Marvig, 31055 Toulouse, France
| | - A Claverie
- CEMES-CNRS and Université de Toulouse, 29 rue J. Marvig, 31055 Toulouse, France
| | - X Marie
- Université de Toulouse, INSA-CNRS-UPS, LPCNO, 135 Avenue Rangueil, 31077 Toulouse, France
| | - C Robert
- Université de Toulouse, INSA-CNRS-UPS, LPCNO, 135 Avenue Rangueil, 31077 Toulouse, France
| | - B Gil
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - G Cassabois
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - V Jacques
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| |
Collapse
|
2
|
Durand A, Clua-Provost T, Fabre F, Kumar P, Li J, Edgar JH, Udvarhelyi P, Gali A, Marie X, Robert C, Gérard JM, Gil B, Cassabois G, Jacques V. Optically Active Spin Defects in Few-Layer Thick Hexagonal Boron Nitride. Phys Rev Lett 2023; 131:116902. [PMID: 37774304 DOI: 10.1103/physrevlett.131.116902] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Accepted: 08/22/2023] [Indexed: 10/01/2023]
Abstract
Optically active spin defects in hexagonal boron nitride (hBN) are promising quantum systems for the design of two-dimensional quantum sensing units offering optimal proximity to the sample being probed. In this Letter, we first demonstrate that the electron spin resonance frequencies of boron vacancy centers (V_{B}^{-}) can be detected optically in the limit of few-atomic-layer thick hBN flakes despite the nanoscale proximity of the crystal surface that often leads to a degradation of the stability of solid-state spin defects. We then analyze the variations of the electronic spin properties of V_{B}^{-} centers with the hBN thickness with a focus on (i) the zero-field splitting parameters, (ii) the optically induced spin polarization rate and (iii) the longitudinal spin relaxation time. This Letter provides important insights into the properties of V_{B}^{-} centers embedded in ultrathin hBN flakes, which are valuable for future developments of foil-based quantum sensing technologies.
Collapse
Affiliation(s)
- A Durand
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - T Clua-Provost
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - F Fabre
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - P Kumar
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - J Li
- Tim Taylor Department of Chemical Engineering, Kansas State University, Kansas 66506, USA
| | - J H Edgar
- Tim Taylor Department of Chemical Engineering, Kansas State University, Kansas 66506, USA
| | - P Udvarhelyi
- Department of Atomic Physics, Budapest University of Technology and Economics, H-1111 Budapest, Hungary
| | - A Gali
- Department of Atomic Physics, Budapest University of Technology and Economics, H-1111 Budapest, Hungary
- Wigner Research Centre for Physics, P.O. Box 49, H-1525 Budapest, Hungary
| | - X Marie
- Université de Toulouse, INSA-CNRS-UPS, LPCNO, 135 Avenue Rangueil, 31077 Toulouse, France
| | - C Robert
- Université de Toulouse, INSA-CNRS-UPS, LPCNO, 135 Avenue Rangueil, 31077 Toulouse, France
| | - J M Gérard
- Univ. Grenoble Alpes, CEA, Grenoble INP, IRIG, PHELIQS, "Nanophysique et Semiconducteurs" Group, F-38000 Grenoble, France
| | - B Gil
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - G Cassabois
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - V Jacques
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| |
Collapse
|
3
|
Delage P, Ségrestin B, Seyssel K, Chanon S, Vieille-Marchiset A, Durand A, Nemeth A, Métairon S, Charpagne A, Descombes P, Hager J, Laville M, Vidal H, Meugnier E. Adipose tissue angiogenesis genes are down-regulated by grape polyphenols supplementation during a human overfeeding trial. J Nutr Biochem 2023; 117:109334. [PMID: 36965784 DOI: 10.1016/j.jnutbio.2023.109334] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 01/16/2023] [Accepted: 03/18/2023] [Indexed: 03/27/2023]
Abstract
The adaptive response to overfeeding is associated with profound modifications of gene expression in adipose tissue to support lipid storage and weight gain. The objective of this study was to assess in healthy lean men whether a supplementation with polyphenols could interact with these molecular adaptations. Abdominal subcutaneous adipose tissue biopsies were sampled from 42 subjects participating to an overfeeding protocol providing an excess of 50% of their total energy expenditure for 31 days, and who were supplemented with 2 g/day of grape polyphenols or a placebo. Gene expression profiling was performed by RNA sequencing. Overfeeding led to a modification of the expression of 163 and 352 genes in the placebo and polyphenol groups, respectively. The GO functions of these genes were mostly involved in lipid metabolism, followed by genes involved in adipose tissue remodeling and expansion. In response to overfeeding, 812 genes were differentially regulated between groups. Among them, a set of 41 genes were related to angiogenesis and were downregulated in the polyphenol group. Immunohistochemistry targeting PECAM1, as endothelial cell marker, confirmed reduced angiogenesis in this group. Finally, quercetin and isorhamnetin, two polyphenol species enriched in the plasma of the volunteers submitted to the polyphenols, were found to inhibit human umbilical vein endothelial cells migration in vitro. Polyphenol supplementation do not prevent the regulation of genes related to lipid metabolism in human adipose tissue during overfeeding, but impact the angiogenesis pathways. This may potentially contribute to a protection against adipose tissue expansion during dynamic phase of weight gain.
Collapse
Affiliation(s)
- Pauline Delage
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| | - Bérénice Ségrestin
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France; Centre Hospitalier Lyon-Sud, Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Pierre-Bénite, F-69100, France.
| | - Kévin Seyssel
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France.
| | - Stéphanie Chanon
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| | | | - Annie Durand
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| | - Angéline Nemeth
- CNRS, INSERM, CREATIS, Université de Lyon, INSA-Lyon, Claude Bernard Lyon 1 University, UJM-Saint Etienne, Lyon, France.
| | | | - Aline Charpagne
- Nestlé Research, EPFL Innovation Park, H, Lausanne, Switzerland.
| | | | - Jörg Hager
- Nestlé Research, EPFL Innovation Park, H, Lausanne, Switzerland.
| | - Martine Laville
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France; Centre Hospitalier Lyon-Sud, Service d'Endocrinologie Diabète Nutrition Lyon, Hospices Civils de Lyon, Pierre-Bénite, F-69100, France.
| | - Hubert Vidal
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France; CRNH-RA, INSERM, INRAe, Claude Bernard Lyon 1 University, Hospices Civils de Lyon, Pierre-Bénite, F-69310, France.
| | - Emmanuelle Meugnier
- CarMeN Laboratory, INSERM, INRAe, Claude Bernard Lyon 1 University, Pierre-Bénite, F-69310, France.
| |
Collapse
|
4
|
Derisoud E, Valais O, Jouneau L, Dubois C, Durand A, Archilla C, Prezelin A, Dahirel M, Jaszczyszyn Y, Wimel L, Duranthon V, Chavatte-Palmer P. 230 Slight alterations of trophoblast gene expression are related to the term placenta morphology and gene expression in horses. Reprod Fertil Dev 2022. [DOI: 10.1071/rdv35n2ab230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
|
5
|
Seshagiri D, Durand A, Morgan C, Lahoz R. Burden of ASCVD in England. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Haykal A, Tanos R, Minotto N, Durand A, Fabre F, Li J, Edgar JH, Ivády V, Gali A, Michel T, Dréau A, Gil B, Cassabois G, Jacques V. Decoherence of V[Formula: see text] spin defects in monoisotopic hexagonal boron nitride. Nat Commun 2022; 13:4347. [PMID: 35896526 PMCID: PMC9329290 DOI: 10.1038/s41467-022-31743-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 06/21/2022] [Indexed: 11/20/2022] Open
Abstract
Spin defects in hexagonal boron nitride (hBN) are promising quantum systems for the design of flexible two-dimensional quantum sensing platforms. Here we rely on hBN crystals isotopically enriched with either 10B or 11B to investigate the isotope-dependent properties of a spin defect featuring a broadband photoluminescence signal in the near infrared. By analyzing the hyperfine structure of the spin defect while changing the boron isotope, we first confirm that it corresponds to the negatively charged boron-vacancy center ([Formula: see text]). We then show that its spin coherence properties are slightly improved in 10B-enriched samples. This is supported by numerical simulations employing cluster correlation expansion methods, which reveal the importance of the hyperfine Fermi contact term for calculating the coherence time of point defects in hBN. Using cross-relaxation spectroscopy, we finally identify dark electron spin impurities as an additional source of decoherence. This work provides new insights into the properties of [Formula: see text] spin defects, which are valuable for the future development of hBN-based quantum sensing foils.
Collapse
Affiliation(s)
- A. Haykal
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - R. Tanos
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - N. Minotto
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - A. Durand
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - F. Fabre
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - J. Li
- Tim Taylor Department of Chemical Engineering, Kansas State University, Manhattan, KS USA
| | - J. H. Edgar
- Tim Taylor Department of Chemical Engineering, Kansas State University, Manhattan, KS USA
| | - V. Ivády
- Max Planck Institute for the Physics of Complex Systems, Dresden, Germany
- Department of Physics, Linköping University, Linköping, Sweden
| | - A. Gali
- Wigner Research Centre for Physics, Budapest, Hungary
- Department of Atomic Physics, Budapest University of Technology and Economics, Budapest, Hungary
| | - T. Michel
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - A. Dréau
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - B. Gil
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - G. Cassabois
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| | - V. Jacques
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, Montpellier, France
| |
Collapse
|
7
|
Delage P, Ségrestin B, Meugnier E, Chanon S, Durand A, Achaintre D, Scalbert A, Vidal H, Laville M. Étude de l’effet des polyphénols sur les mécanismes précoces de prise de poids chez des sujets sains soumis à un mois de surnutrition : focus sur le tissu adipeux. NUTR CLIN METAB 2022. [DOI: 10.1016/j.nupar.2021.12.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
8
|
Gouni-Berthold I, Seshagiri D, Studer R, Durand A, Klebs S, Achouba A, Morgan C, Kap E, Lahoz R. Treatment patterns in patients with Familial hypercholesterolemia: evidence from real-world studies in Germany and the UK. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Familial hypercholesterolemia (FH) includes a spectrum of disease as per the number and effect of mutations in specific proteins involved in low-density lipoprotein cholesterol (LDL-C) metabolism, together with other genetic factors. Elevated LDL-C levels have been strongly associated with risk of cardiovascular and coronary heart disease, with up to 10-fold risk in patients (pts) with FH than without FH. The aim of lipid-lowering treatments (LLTs) is to reduce the LDL-C levels, although there is limited research describing treatment patterns and LDL-C outcomes in FH pts in routine care.
Purpose
To characterize the treatment patterns and LDL-C outcomes of FH pts in the real-world setting in Germany (GER) and the UK.
Methods
We conducted two descriptive, non-interventional and retrospective cohort studies. Pts in GER were identified from General Physician (GP) and Cardiology practices available in electronic medical records database Disease Analyzer (January 1992-June 2020). Pts in the UK were identified from the Clinical Practice Research Datalink linked to the Hospital Episode Statistics admitted pts care and Office of National Statistics datasets. Pts were included if they had diagnosis of FH (index date [ID]) and data available within 6-month before and 3-month after the ID. The first diagnosis of FH in the identification period (GER, 1/07/2015–30/06/2019; UK, 01/01/2010–31/05/2018) was considered the ID. Persistence and adherence to the recorded LLT at ID was analyzed for pts with at least 12 months and 24 months of follow-up. Persistence was measured as the duration (in days) with allowed gap of 60 days and adherence as proportion of days covered (PDC).
Results
Analysis included 2,105 FH pts from GER and 9,846 from the UK. Data are presented as GER/UK. The mean (SD) age of pts was 60 (15)/52 (14) years, and 60%/61% were females. Hypertension (53%/27%) and depression (31%/38%) were the common comorbidities. At ID, statin monotherapy (29%/68%) was the most commonly prescribed LLT. The use of ezetimibe, fibrates and PCSK9 inhibitors was very low in both countries (Table 1). Of note, LDL-C measurements at ID (−6m/+3m) were available for 31%/73% of pts. In pts with uncontrolled LDL-C (≥55 mg/dL), 34%/64% were receiving statin monotherapy, whereas there was no use of LLT in 62%/29% of pts. During the 24 months follow-up, the mean (SD) persistence and PDC to statins monotherapy was 471 (264)/489 (289) days and 0.65 (0.36)/0.69 (0.46), respectively, with 50%/70% of pts being adherent (PDC ≥0.80).
Conclusions
In our study, in GER, the rate of LDL-C measurements was low. In both GER and UK, almost all measured patients had LDL-C ≥55mg/dL at ID. Findings indicate low prescriptions of LLTs in GP setting, particularly non-statin LLTs in both countries. The mean adherence (PDC) in GER and the UK was 65% and 69%, respectively within 24 months after ID. Improved LDL-C monitoring and new therapies with potential to lower LDL-C are warranted.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): Novartis Pharma AG, Basel, Switzerland
Collapse
Affiliation(s)
| | | | - R Studer
- Novartis Pharma AG, Basel, Switzerland
| | - A Durand
- Novartis Pharmaceuticals, London, United Kingdom
| | - S Klebs
- Novartis Pharma GmbH, Nürnberg, Germany
| | - A Achouba
- Novartis Pharma AG, Basel, Switzerland
| | - C Morgan
- Pharmatelligence, Cardiff, United Kingdom
| | - E Kap
- IQVIA, Frankfurt, Germany
| | - R Lahoz
- Novartis Pharma AG, Basel, Switzerland
| |
Collapse
|
9
|
Gouriou Y, Alam MR, Harhous Z, Da Silva CC, Baetz D, Badawi S, Lefai E, Rieusset J, Durand A, Harisseh R, Gharib A, Ovize M, Bidaux G. Addendum: Gouriou et al. ANT2-Mediated ATP Import into Mitochondria Protects against Hypoxia Lethal Injury. Cells 2020, 9, 2542. Cells 2021. [PMCID: PMC8471286 DOI: 10.3390/cells10092171] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
The authors and the Cells Editorial Office would like to add the section “Materials and Methods”, which was missing in the original version [...]
Collapse
Affiliation(s)
- Yves Gouriou
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Correspondence: (Y.G.); (G.B.)
| | - Muhammad Rizwan Alam
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Department of Biochemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan
| | - Zeina Harhous
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Gilbert and Rose-Marie Chagoury, School of Medicine, Lebanese American University, Byblos 4M8F+8X, Lebanon
| | - Claire Crola Da Silva
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Delphine Baetz
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Sally Badawi
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Etienne Lefai
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Jennifer Rieusset
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Annie Durand
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Rania Harisseh
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Abdallah Gharib
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Michel Ovize
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Gabriel Bidaux
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Correspondence: (Y.G.); (G.B.)
| |
Collapse
|
10
|
Lahoz R, Seshagiri D, Achouba A, Durand A, Morgan C, Berni T, Studer R. Treatment patterns in atherosclerotic cardiovascular disease (ASCVD-H) and ASCVD-risk equivalent (ASCVD-RE-H) patients, both with hypercholesterolemia, a retrospective real-world database analysis in England. Atherosclerosis 2021. [DOI: 10.1016/j.atherosclerosis.2021.06.788] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Lhermitte B, Blandin AF, Coca A, Guerin E, Durand A, Entz-Werlé N. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas. Neurochirurgie 2021; 67:39-45. [PMID: 29776650 DOI: 10.1016/j.neuchi.2018.01.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2017] [Revised: 01/06/2018] [Accepted: 01/13/2018] [Indexed: 12/21/2022]
Abstract
Medulloblastomas (MBs) account for 15% of brain tumors in children under the age of 15. To date, the overall 5-year survival rate for all children is only around 60%. Recent advances in cancer genomics have led to a fundamental change in medulloblastoma classification and is evolving along with the genomic discoveries, allowing to regularly reclassify this disease. The previous molecular classification defined 4 groups (WNT-activated MB, SHH-activated MB and the groups 3 and 4 characterized partially by NMYC and MYC driven MBs). This stratification moved forward recently to better define these groups and their correlation to outcome. This new stratification into 7 novel subgroups was helpful to lay foundations and complementary data on the understanding regarding molecular pathways and gene mutations underlying medulloblastoma biology. This review was aimed at answering the recent key questions on MB genomics and go further in the relevance of those genes in MB development as well as in their targeted therapies.
Collapse
Affiliation(s)
- B Lhermitte
- Laboratoire de Pathologie, CHU Hautepierre, 1, avenue Molière, 67098 Strasbourg, France
| | - A F Blandin
- EA3430, Progression tumorale et microenvironnement, approches translationnelles et épidémiologie, université de Strasbourg, 3, avenue Molière, 67000 Strasbourg, France
| | - A Coca
- Service de Neurochirurgie, CHU Hautepierre, 1, avenue Molière, 67098 Strasbourg, France
| | - E Guerin
- Laboratoire de biologie moléculaire et plateforme régionale d'oncobiologie d'Alsace, CHU Hautepierre, 1, avenue Molière, 67098 Strasbourg, France
| | - A Durand
- EA3430, Progression tumorale et microenvironnement, approches translationnelles et épidémiologie, université de Strasbourg, 3, avenue Molière, 67000 Strasbourg, France
| | - N Entz-Werlé
- EA3430, Progression tumorale et microenvironnement, approches translationnelles et épidémiologie, université de Strasbourg, 3, avenue Molière, 67000 Strasbourg, France; Service de pédiatrie onco-hématologie, CHU Hautepierre, 1, avenue Molière, 67098 Strasbourg, France.
| |
Collapse
|
12
|
Grundy MM, Abrahamse E, Almgren A, Alminger M, Andres A, Ariëns RM, Bastiaan-Net S, Bourlieu-Lacanal C, Brodkorb A, Bronze MR, Comi I, Couëdelo L, Dupont D, Durand A, El SN, Grauwet T, Heerup C, Heredia A, Infantes Garcia MR, Jungnickel C, Kłosowska-Chomiczewska IE, Létisse M, Macierzanka A, Mackie AR, McClements DJ, Menard O, Meynier A, Michalski MC, Mulet-Cabero AI, Mullertz A, Payeras Perelló FM, Peinado I, Robert M, Secouard S, Serra AT, Silva SD, Thomassen G, Tullberg C, Undeland I, Vaysse C, Vegarud GE, Verkempinck SH, Viau M, Zahir M, Zhang R, Carrière F. INFOGEST inter-laboratory recommendations for assaying gastric and pancreatic lipases activities prior to in vitro digestion studies. J Funct Foods 2021. [DOI: 10.1016/j.jff.2021.104497] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
13
|
Figueiredo A, Strekowski RS, Bosland L, Durand A, Wortham H. Photodegradation of Molecular Iodine on SiO2 Particles: Influence of Temperature and Relative Humidity. Journal of Nuclear Engineering and Radiation Science 2021. [DOI: 10.1115/1.4048846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Abstract
A molecular derivatization method followed by gas chromatographic separation coupled with mass spectrometric detection was used to study photodegradation of molecular I2 adsorbed on solid SiO2 particles. The heterogeneous photodegradation of I2 was studied as a function of temperature and relative humidity in synthetic air to better understand its environmental fate. Two sets of experiments were carried out. In the first set of experiments, the temperature was T = (298 ± 1) K and relative humidity was varied from ≤ 2% to 75%RH under given experimental conditions. In the second set of experiments, the relative humidity within the Pyrex bulb was 40%RH and the temperature was varied from 283 ± 1 ≤ T (K) ≤ 323 ± 1. The obtained results show a considerably enhanced atmospheric lifetime of molecular iodine adsorbed on solid media that does not depend on relative humidity of the environment. The obtained results show that the rate constant for the photolysis of molecular iodine adsorbed on model SiO2 particles depends on temperature and is reported to be J (T)=(1.24 ± 1.4)×10−2×exp[(1482±345)/T]/s over the measured temperature range. The heterogeneous atmospheric residence time () of I2 adsorbed on solid media is calculated to range from 2 to 4.1 h. The experimentally obtained heterogeneous lifetime of I2 is shown to be considerably longer than its destruction by its principal atmospheric sink, photolysis. The observed enhanced atmospheric lifetime of I2 on heterogeneous media will likely have direct consequences on the atmospheric transport of I2 that influences the toxicity or the oxidative capacity of the atmosphere.
Collapse
Affiliation(s)
- A. Figueiredo
- Aix Marseille University, CNRS, LCE, Marseille 13007, France; Institut de Radioprotection et de Sûreté Nucléaire, PSN-RES/SAG/LETR, Cadarache, France
| | | | - L. Bosland
- Institut de Radioprotection et de Sûreté Nucléaire, PSN-RES/SAG/LETR, Cadarache, France
| | - A. Durand
- Aix Marseille University, CNRS, LCE, Marseille 13007, France
| | - H. Wortham
- Aix Marseille University, CNRS, LCE, Marseille 13007, France
| |
Collapse
|
14
|
Le Barz M, Vors C, Combe E, Joumard-Cubizolles L, Lecomte M, Joffre F, Trauchessec M, Pesenti S, Loizon E, Breyton AE, Meugnier E, Bertrand K, Drai J, Robert C, Durand A, Cuerq C, Gaborit P, Leconte N, Bernalier-Donadille A, Cotte E, Laville M, Lambert-Porcheron S, Ouchchane L, Vidal H, Malpuech-Brugère C, Cheillan D, Michalski MC. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women. JCI Insight 2021; 6:146161. [PMID: 33857018 PMCID: PMC8262315 DOI: 10.1172/jci.insight.146161] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Accepted: 04/09/2021] [Indexed: 01/16/2023] Open
Abstract
BACKGROUND High circulating levels of ceramides (Cer) and sphingomyelins (SM) are associated with cardiometabolic diseases. The consumption of whole fat dairy products, naturally containing such polar lipids (PL), is associated with health benefits, but the impact on sphingolipidome remains unknown. METHODS In a 4-week randomized controlled trial, 58 postmenopausal women daily consumed milk PL-enriched cream cheese (0, 3, or 5 g of milk PL). Postprandial metabolic explorations were performed before and after supplementation. Analyses included SM and Cer species in serum, chylomicrons, and feces. The ileal contents of 4 ileostomy patients were also explored after acute milk PL intake. RESULTS Milk PL decreased serum atherogenic C24:1 Cer, C16:1 SM, and C18:1 SM species (Pgroup < 0.05). Changes in serum C16+18 SM species were positively correlated with the reduction of cholesterol (r = 0.706), LDL-C (r = 0.666), and ApoB (r = 0.705) (P < 0.001). Milk PL decreased chylomicron content in total SM and C24:1 Cer (Pgroup < 0.001), parallel to a marked increase in total Cer in feces (Pgroup < 0.001). Milk PL modulated some specific SM and Cer species in both ileal efflux and feces, suggesting differential absorption and metabolization processes in the gut. CONCLUSION Milk PL supplementation decreased atherogenic SM and Cer species associated with the improvement of cardiovascular risk markers. Our findings bring insights on sphingolipid metabolism in the gut, especially Cer, as signaling molecules potentially participating in the beneficial effects of milk PL. TRIAL REGISTRATION ClinicalTrials.gov, NCT02099032, NCT02146339. FUNDING ANR-11-ALID-007-01; PHRCI-2014: VALOBAB, no. 14-007; CNIEL; GLN 2018-11-07; HCL (sponsor).
Collapse
Affiliation(s)
- Mélanie Le Barz
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Cécile Vors
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Emmanuel Combe
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Laurie Joumard-Cubizolles
- Université Clermont Auvergne, INRAE, UNH, Unité de Nutrition Humaine, CRNH Auvergne, 63000, Clermont-Ferrand, France
| | - Manon Lecomte
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Florent Joffre
- ITERG, ZA Pessac-Canéjan, 11 Rue Gaspard Monge, 33610, Canéjan, France
| | - Michèle Trauchessec
- Hospices Civils de Lyon, 69000, Lyon, France.,Unité Maladies Héréditaires du Métabolisme, Service de Biochimie et Biologie Moléculaire Grand Est, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69677, Bron, France
| | - Sandra Pesenti
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Emmanuelle Loizon
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Anne-Esther Breyton
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Emmanuelle Meugnier
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Karène Bertrand
- ITERG, ZA Pessac-Canéjan, 11 Rue Gaspard Monge, 33610, Canéjan, France
| | - Jocelyne Drai
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Unité de Nutrition Endocrinologie Métabolisme, Service de Biochimie, Centre de Biologie et de Pathologie Sud, Hospices Civils de Lyon, 69495, Pierre-Bénite, France
| | - Chloé Robert
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| | - Annie Durand
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Charlotte Cuerq
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Unité de Nutrition Endocrinologie Métabolisme, Service de Biochimie, Centre de Biologie et de Pathologie Sud, Hospices Civils de Lyon, 69495, Pierre-Bénite, France
| | - Patrice Gaborit
- ACTALIA Dairy Products and Technologies, Avenue François Mitterrand, BP49, 17700, Surgères, France.,ENILIA ENSMIC, Avenue François Mitterrand, 17700, Surgères, France
| | - Nadine Leconte
- INRAE, Institut Agro, STLO (Science et Technologie du Lait et de l'Œuf), 35042, Rennes, France
| | | | - Eddy Cotte
- Hospices Civils de Lyon, 69000, Lyon, France.,Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service de chirurgie digestive, 69310, Pierre-Bénite, France.,Université Claude Bernard Lyon 1, Faculté de médecine Lyon-Sud-Charles Mérieux, EMR 3738, 69600, Oullins, France
| | - Martine Laville
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Université Claude Bernard Lyon 1, Faculté de médecine Lyon-Sud-Charles Mérieux, EMR 3738, 69600, Oullins, France
| | - Stéphanie Lambert-Porcheron
- TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France
| | - Lemlih Ouchchane
- Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, 63000, Clermont-Ferrand, France.,CHU Clermont-Ferrand, Unité de Biostatistique-Informatique Médicale, 63000, Clermont-Ferrand, France
| | - Hubert Vidal
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France
| | - Corinne Malpuech-Brugère
- Université Clermont Auvergne, INRAE, UNH, Unité de Nutrition Humaine, CRNH Auvergne, 63000, Clermont-Ferrand, France
| | - David Cheillan
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,Hospices Civils de Lyon, 69000, Lyon, France.,Unité Maladies Héréditaires du Métabolisme, Service de Biochimie et Biologie Moléculaire Grand Est, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69677, Bron, France
| | - Marie-Caroline Michalski
- Univ Lyon, CarMeN laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon 1, Charles Mérieux Medical School, 69310, Pierre-Bénite, France.,TCentre de Recherche en Nutrition Humaine Rhône-Alpes, Univ-Lyon, CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices Civils de Lyon, CENS, FCRIN/FORCE Network, 69310, Pierre-Bénite, France
| |
Collapse
|
15
|
Gaulier JM, Onimus T, Durand A, Goutay J, Hennart B, Hakim F, Richeval C, Wiart J, Humbert L, Allorge D. Screening toxicologique par spectrométrie de masse haute résolution en 24/24 : l’outil de l’avenir ? Suivi toxicocinétique en temps réel d’une intoxication par médicaments cardiotropes. Toxicologie Analytique et Clinique 2021. [DOI: 10.1016/j.toxac.2020.10.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
16
|
Durand A, Baron Y, Redjem W, Herzig T, Benali A, Pezzagna S, Meijer J, Kuznetsov AY, Gérard JM, Robert-Philip I, Abbarchi M, Jacques V, Cassabois G, Dréau A. Broad Diversity of Near-Infrared Single-Photon Emitters in Silicon. Phys Rev Lett 2021; 126:083602. [PMID: 33709758 DOI: 10.1103/physrevlett.126.083602] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Accepted: 01/21/2021] [Indexed: 05/28/2023]
Abstract
We report the detection of individual emitters in silicon belonging to seven different families of optically active point defects. These fluorescent centers are created by carbon implantation of a commercial silicon-on-insulator wafer usually employed for integrated photonics. Single photon emission is demonstrated over the 1.1-1.55 μm range, spanning the O and C telecom bands. We analyze their photoluminescence spectra, dipolar emissions, and optical relaxation dynamics at 10 K. For a specific family, we show a constant emission intensity at saturation from 10 K to temperatures well above the 77 K liquid nitrogen temperature. Given the advanced control over nanofabrication and integration in silicon, these individual artificial atoms are promising systems to investigate for Si-based quantum technologies.
Collapse
Affiliation(s)
- A Durand
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - Y Baron
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - W Redjem
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - T Herzig
- Division of Applied Quantum Systems, Felix-Bloch Institute for Solid-State Physics, University Leipzig, Linnéestraße 5, 04103 Leipzig, Germany
| | - A Benali
- CNRS, Aix-Marseille Université, Centrale Marseille, IM2NP, UMR 7334, Campus de St. Jérôme, 13397 Marseille, France
| | - S Pezzagna
- Division of Applied Quantum Systems, Felix-Bloch Institute for Solid-State Physics, University Leipzig, Linnéestraße 5, 04103 Leipzig, Germany
| | - J Meijer
- Division of Applied Quantum Systems, Felix-Bloch Institute for Solid-State Physics, University Leipzig, Linnéestraße 5, 04103 Leipzig, Germany
| | - A Yu Kuznetsov
- Department of Physics, University of Oslo, NO-0316 Oslo, Norway
| | - J-M Gérard
- Department of Physics, IRIG-PHELIQS, Univ. Grenoble Alpes and CEA, F-38000 Grenoble, France
| | - I Robert-Philip
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - M Abbarchi
- CNRS, Aix-Marseille Université, Centrale Marseille, IM2NP, UMR 7334, Campus de St. Jérôme, 13397 Marseille, France
| | - V Jacques
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - G Cassabois
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| | - A Dréau
- Laboratoire Charles Coulomb, Université de Montpellier and CNRS, 34095 Montpellier, France
| |
Collapse
|
17
|
Chardin C, Durand A, Jarsalé K, Rouden J, Livi S, Baudoux J. Sulfonimides versus ketosulfonamides as epoxidized imidazolium counterions: towards a new generation of ionic liquid monomers. NEW J CHEM 2021. [DOI: 10.1039/d0nj05126h] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Ionic liquid monomers with various sulfonimides or ketosulfonamides as unprecedented counteranions of imidazolium ILs were submitted to the Prilezhaev reaction and the intrinsic properties of these new epoxy monomers was unveiled.
Collapse
Affiliation(s)
- C. Chardin
- Laboratoire de Chimie Moléculaire et Thio-organique
- ENSICAEN
- Université de Caen Normandie
- CNRS
- 6 boulevard du Maréchal Juin
| | - A. Durand
- Laboratoire de Chimie Moléculaire et Thio-organique
- ENSICAEN
- Université de Caen Normandie
- CNRS
- 6 boulevard du Maréchal Juin
| | - K. Jarsalé
- Laboratoire de Chimie Moléculaire et Thio-organique
- ENSICAEN
- Université de Caen Normandie
- CNRS
- 6 boulevard du Maréchal Juin
| | - J. Rouden
- Laboratoire de Chimie Moléculaire et Thio-organique
- ENSICAEN
- Université de Caen Normandie
- CNRS
- 6 boulevard du Maréchal Juin
| | - S. Livi
- Université de Lyon
- INSA Lyon
- UMR CNRS 5223
- IMP Ingénierie des Matériaux Polymères
- Villeurbanne F-69621
| | - J. Baudoux
- Laboratoire de Chimie Moléculaire et Thio-organique
- ENSICAEN
- Université de Caen Normandie
- CNRS
- 6 boulevard du Maréchal Juin
| |
Collapse
|
18
|
Gouriou Y, Alam MR, Harhous Z, Crola Da Silva C, Baetz DB, Badawi S, Lefai E, Rieusset J, Durand A, Harisseh R, Gharib A, Ovize M, Bidaux G. ANT2-Mediated ATP Import into Mitochondria Protects against Hypoxia Lethal Injury. Cells 2020; 9:cells9122542. [PMID: 33255741 PMCID: PMC7760820 DOI: 10.3390/cells9122542] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Revised: 11/12/2020] [Accepted: 11/24/2020] [Indexed: 12/16/2022] Open
Abstract
Following a prolonged exposure to hypoxia–reoxygenation, a partial disruption of the ER-mitochondria tethering by mitofusin 2 (MFN2) knock-down decreases the Ca2+ transfer between the two organelles limits mitochondrial Ca2+ overload and prevents the Ca2+-dependent opening of the mitochondrial permeability transition pore, i.e., limits cardiomyocyte cell death. The impact of the metabolic changes resulting from the alteration of this Ca2+crosstalk on the tolerance to hypoxia–reoxygenation injury remains partial and fragmented between different field of expertise. >In this study, we report that MFN2 loss of function results in a metabolic switch driven by major modifications in energy production by mitochondria. During hypoxia, mitochondria maintain their ATP concentration and, concomitantly, the inner membrane potential by importing cytosolic ATP into mitochondria through an overexpressed ANT2 protein and by decreasing the expression and activity of the ATP hydrolase via IF1. This adaptation further blunts the detrimental hyperpolarisation of the inner mitochondrial membrane (IMM) upon re-oxygenation. These metabolic changes play an important role to attenuate cell death during a prolonged hypoxia–reoxygenation challenge.
Collapse
Affiliation(s)
- Yves Gouriou
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Correspondence: (Y.G.); (G.B.)
| | - Muhammad Rizwan Alam
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Department of Biochemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan
| | - Zeina Harhous
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Gilbert and Rose-Marie Chagoury, School of Medicine, Lebanese American University, Byblos 4M8F+8X, Lebanon
| | - Claire Crola Da Silva
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Delphine Baetz Baetz
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Sally Badawi
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Etienne Lefai
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Jennifer Rieusset
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Annie Durand
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Rania Harisseh
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Abdallah Gharib
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Michel Ovize
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
| | - Gabriel Bidaux
- Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France, IHU OPERA, Groupement Hospitalier EST, Bâtiment B13, 59 boulevard Pinel, F-69500 Bron, France; (M.R.A.); (Z.H.); (C.C.D.S.); (D.B.B.); (S.B.); (E.L.); (J.R.); (A.D.); (R.H.); (A.G.); (M.O.)
- Correspondence: (Y.G.); (G.B.)
| |
Collapse
|
19
|
Vincent M, Ménard O, Etienne J, Ossemond J, Durand A, Buffin R, Loizon E, Meugnier E, Deglaire A, Dupont D, Picaud JC, Knibbe C, Michalski MC, Penhoat A. Human milk pasteurisation reduces pre-lipolysis but not digestive lipolysis and moderately decreases intestinal lipid uptake in a combination of preterm infant in vitro models. Food Chem 2020; 329:126927. [PMID: 32516717 DOI: 10.1016/j.foodchem.2020.126927] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2020] [Revised: 04/24/2020] [Accepted: 04/26/2020] [Indexed: 11/19/2022]
Abstract
Donor human milk, pasteurised for safety reasons, is the first alternative for feeding preterm infants when mothers' own milk is unavailable. Breastmilk pasteurisation impact on lipid digestion and absorption was evaluated by a static in vitro digestion model for preterm infants coupled with intestinal absorption using Caco-2/TC7 cells. Lipid absorption was quantified by digital image analysis of lipid droplets, by measurement of basolateral triglyceride concentration and by analysing the expression of major genes involved. After in vitro digestion, lipolysis extent was 13% lower in pasteurised human milk (PHM) than in raw human milk (RHM). In Caco-2/TC7 cells, the number of lipid droplets was identical for both milk types, while the mean droplet area was 17% smaller with PHM. Altogether, pasteurisation decreased the pre-lipolysis of human milk. This initial difference in free fatty acid amount was only partially buffered by the subsequent processes of in vitro digestion and cellular lipid absorption.
Collapse
Affiliation(s)
- Marine Vincent
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France; Neonatology Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
| | | | - Julie Etienne
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France; Project-Team BEAGLE, INRIA, Villeurbanne, France.
| | | | - Annie Durand
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Villeurbanne, France.
| | - Rachel Buffin
- Neonatology Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
| | - Emmanuelle Loizon
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | - Emmanuelle Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | | | | | - Jean-Charles Picaud
- Neonatology Department, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France; Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | - Carole Knibbe
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France; Project-Team BEAGLE, INRIA, Villeurbanne, France.
| | - Marie-Caroline Michalski
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| | - Armelle Penhoat
- Univ Lyon, CarMeN Laboratory, INSERM, INRAE, INSA Lyon, Université Claude Bernard Lyon1, Pierre-Bénite, France.
| |
Collapse
|
20
|
Rabia M, Leuzy V, Soulage C, Durand A, Fourmaux B, Errazuriz-Cerda E, Köffel R, Draeger A, Colosetti P, Jalabert A, Di Filippo M, Villard-Garon A, Bergerot C, Luquain-Costaz C, Moulin P, Rome S, Delton I, Hullin-Matsuda F. Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles. Biochimie 2020; 178:26-38. [PMID: 32659447 DOI: 10.1016/j.biochi.2020.07.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 06/29/2020] [Accepted: 07/08/2020] [Indexed: 01/05/2023]
Abstract
Bis(monoacylglycero)phosphate (BMP), also known as lysobisphosphatidic acid (LBPA), is a phospholipid specifically enriched in the late endosome-lysosome compartment playing a crucial role for the fate of endocytosed components. Due to its presence in extracellular fluids during diseases associated with endolysosomal dysfunction, it is considered as a possible biomarker of disorders such as genetic lysosomal storage diseases and cationic amphiphilic drug-induced phospholipidosis. However, there is no true validation of this biomarker in human studies, nor a clear identification of the carrier of this endolysosome-specific lipid in biofluids. The present study demonstrates that in absence of any sign of renal failure, BMP, especially all docosahexaenoyl containing species, are significantly increased in the urine of patients treated with the antiarrhythmic drug amiodarone. Such urinary BMP increase could reflect a generalized drug-induced perturbation of the endolysosome compartment as observed in vitro with amiodarone-treated human macrophages. Noteworthy, BMP was associated with extracellular vesicles (EVs) isolated from human urines and extracellular medium of human embryonic kidney HEK293 cells and co-localizing with classical EV protein markers CD63 and ALIX. In the context of drug-induced endolysosomal dysfunction, increased BMP-rich EV release could be useful to remove excess of undigested material. This first human pilot study not only reveals BMP as a urinary biomarker of amiodarone-induced endolysosomal dysfunction, but also highlights its utility to prove the endosomal origin of EVs, also named as exosomes. This peculiar lipid already known as a canonical late endosome-lysosome marker, may be thus considered as a new lipid marker of urinary exosomes.
Collapse
Affiliation(s)
- Maxence Rabia
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Valentin Leuzy
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Christophe Soulage
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Annie Durand
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Baptiste Fourmaux
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France; Functional Lipidomics Platform, CarMeN Laboratory / IMBL-INSA Lyon, 69621, Villeurbanne Cedex, France
| | | | - René Köffel
- Department of Cell Biology, Institute of Anatomy, University of Bern, Bern, Switzerland
| | - Annette Draeger
- Department of Cell Biology, Institute of Anatomy, University of Bern, Bern, Switzerland
| | - Pascal Colosetti
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Audrey Jalabert
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Mathilde Di Filippo
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France; Department of Biochemistry and Molecular Biology, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France
| | - Audrey Villard-Garon
- Department of Endocrinology, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Lyon, Bron, France
| | - Cyrille Bergerot
- Department of Cardiology, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Lyon, Bron, France
| | - Céline Luquain-Costaz
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Philippe Moulin
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France; Department of Endocrinology, Hôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Lyon, Bron, France
| | - Sophie Rome
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | - Isabelle Delton
- Univ-Lyon, CarMeN Laboratory, Inserm U1060, INRAe U1397, INSA Lyon, Villeurbanne, France
| | | |
Collapse
|
21
|
Figueiredo A, Strekowski RS, Bosland L, Durand A, Wortham H. Photolytic degradation of molecular iodine adsorbed on model SiO 2 particles. Sci Total Environ 2020; 723:137951. [PMID: 32392691 DOI: 10.1016/j.scitotenv.2020.137951] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 03/11/2020] [Accepted: 03/13/2020] [Indexed: 06/11/2023]
Abstract
A molecular derivatization method followed by gas chromatographic separation coupled with mass spectrometric detection was used to study photolytic degradation of I2 adsorbed on solid SiO2 particles. This heterogeneous photodegradation of I2 is studied at ambient temperature in synthetic air to better understand I2 atmospheric dispersion and environmental fate. The obtained laboratory results show a considerably enhanced atmospheric lifetime of molecular iodine adsorbed on solid media. The heterogeneous atmospheric residence time (τ) of I2 is calculated to be τ ≈ 187 min, i.e., τ ≈ 3 h. The obtained heterogeneous lifetime of I2 is shown to be considerably longer than its destruction by its principal atmospheric sink, namely, photolysis. The observed enhanced atmospheric lifetime of I2 on heterogeneous media will likely have direct consequences on the atmospheric transport of I2 that influences the toxicity or the oxidative capacity of the atmosphere.
Collapse
Affiliation(s)
- A Figueiredo
- Aix Marseille Univ, CNRS, LCE, Marseille, France; Institut de Radioprotection et de Sûreté Nucléaire, PSN-RES/SAG/LETR, Cadarache, France
| | | | - L Bosland
- Institut de Radioprotection et de Sûreté Nucléaire, PSN-RES/SAG/LETR, Cadarache, France
| | - A Durand
- Aix Marseille Univ, CNRS, LCE, Marseille, France
| | - H Wortham
- Aix Marseille Univ, CNRS, LCE, Marseille, France
| |
Collapse
|
22
|
Debono B, Hamel O, Guillain A, Durand A, Rué M, Sabatier P, Lonjon G, Dran G. Impact of malpractice liability among spine surgeons: A national survey of French private neurosurgeons. Neurochirurgie 2020; 66:219-224. [PMID: 32540341 DOI: 10.1016/j.neuchi.2020.05.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2020] [Revised: 04/03/2020] [Accepted: 05/02/2020] [Indexed: 10/24/2022]
Abstract
PURPOSE In the general context of medical judicialization, spine surgeons are impacted by the part that medical responsibility and the risk of malpractice play in their actions and decisions. Our aim was to evaluate possible shifts in practices among private neurosurgeons who are highly exposed to this judicial risk and detect alterations in their pleasure in exercising their profession. We present the first national survey on French physicians' perception of surgical judicialization and consequences on their practice. METHODS An online survey was submitted to the 121 members of the French Society of Private Neurosurgery, who represent 29.1% of the total number of spine surgeons and perform 36.0% of the national total spine surgery activity. The French law (no-fault out-of-court scheme) significantly impacts these surgeons in the event of litigation. RESULTS A total of 78 surveys were completed (64.5% response rate): 89.7% of respondents experienced alteration of doctor-patient relationship related to judicialization and 60.2% had already refused to perform risky surgeries. Fear of being sued added negative pressure during surgery for 55.1% of respondents and 37.2% of them had already considered stopping their practice because of this litigation context. CONCLUSION The increasing impact of medical liability is prompting practitioners to change their practice and perceptions. The doctor-patient relationship appears to be altered, negative pressure is placed on physicians and defensively, some neurosurgeons may refuse high-risk patients and procedures. This situation causes professional disenchantment and can ultimately prove disadvantageous for both doctors and patients.
Collapse
Affiliation(s)
- B Debono
- Ramsay-clinique des cèdres, neurosurgery, Cornebarrieu, France.
| | - O Hamel
- Ramsay-clinique des cèdres, neurosurgery, Cornebarrieu, France
| | - A Guillain
- Sorbonne study group on methods of sociological analysis of the Sorbonne (GEMASS), Sorbonne university, Paris, France; SiRIC CURAMUS (Integrated cancer research site), Assistance publique-Hôpitaux de Paris, Sorbonne university, Paris, France
| | - A Durand
- Infirmerie protestante, neurosurgery, Caluire, France
| | - M Rué
- Endoscopic spine center, Bordeaux, France
| | - P Sabatier
- Ramsay-clinique des cèdres, neurosurgery, Cornebarrieu, France
| | - G Lonjon
- Orthosud, spine surgery department, Montpellier, France
| | - G Dran
- Clinique du millénaire, neurosurgery, Montpellier, France
| | | |
Collapse
|
23
|
Durand A, Cartier L, Duburcq T, Onimus T, Favory R, Preau S. [Causes, diagnosis and treatments of circulatory shocks]. Rev Med Interne 2019; 40:799-807. [PMID: 31668884 DOI: 10.1016/j.revmed.2019.08.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2018] [Revised: 08/02/2019] [Accepted: 08/14/2019] [Indexed: 12/12/2022]
Abstract
Shock states are the leading causes of intensive care admission and are nowadays associated with high morbidity and mortality. They are driven by a complex physiopathology and most frequently a multifactorial mechanism. They can be separated in whether a decrease of oxygen delivery (quantitative shock) or an abnormal cell distribution of cardiac output (distributive shock). Septic, cardiogenic and hypovolemic shocks represent more than 80% of shock etiologies. Clinical presentation is mostly characterized by frequent arterial hypotension and sign of poor clinical perfusion. Hyperlactatemia occurs in most of shock states. The diagnostic of shock or earlier reversible "pre-shock" states is urgent in order to initiate adequate therapy. Therefore, orientation and therapies must be discussed with intensive care physiologists in a multidisciplinary approach. Etiologic investigation and correction is a primary concern. Hemodynamic and respiratory support reflect another part of initial therapy toward normalization of cell oxygenation. Fluid resuscitation is the corner stone part of initial therapy of any form of shock. Vasoconstrictive drugs or inotropic support still often remain necessary. The primary goal of initial resuscitation should be not only to restore blood arterial pressure but also to improve clinical perfusion markers. On the biological side, decrease of lactate concentration is associated with better outcome.
Collapse
Affiliation(s)
- A Durand
- Service de réanimation, hôpital Roger-Salengro, CHU Lille, avenue du Pr.-Emile-Laine, 59000 Lille, France; Inserm, U995 - LIRIC - Lille Inflammation Research International Center, pôle recherche, faculté de médecine de Lille, 5-(e) étage, université Lille, boulevard Pr.-Jules-Leclercq, 59000 Lille, France
| | - L Cartier
- Service de réanimation, hôpital Roger-Salengro, CHU Lille, avenue du Pr.-Emile-Laine, 59000 Lille, France
| | - T Duburcq
- Service de réanimation, hôpital Roger-Salengro, CHU Lille, avenue du Pr.-Emile-Laine, 59000 Lille, France
| | - T Onimus
- Service de réanimation, hôpital Roger-Salengro, CHU Lille, avenue du Pr.-Emile-Laine, 59000 Lille, France
| | - R Favory
- Service de réanimation, hôpital Roger-Salengro, CHU Lille, avenue du Pr.-Emile-Laine, 59000 Lille, France; Inserm, U995 - LIRIC - Lille Inflammation Research International Center, pôle recherche, faculté de médecine de Lille, 5-(e) étage, université Lille, boulevard Pr.-Jules-Leclercq, 59000 Lille, France
| | - S Preau
- Service de réanimation, hôpital Roger-Salengro, CHU Lille, avenue du Pr.-Emile-Laine, 59000 Lille, France; Inserm, U995 - LIRIC - Lille Inflammation Research International Center, pôle recherche, faculté de médecine de Lille, 5-(e) étage, université Lille, boulevard Pr.-Jules-Leclercq, 59000 Lille, France.
| |
Collapse
|
24
|
Danthine S, Vors C, Agopian D, Durand A, Guyon R, Carriere F, Knibbe C, Létisse M, Michalski MC. Homogeneous triacylglycerol tracers have an impact on the thermal and structural properties of dietary fat and its lipolysis rate under simulated physiological conditions. Chem Phys Lipids 2019; 225:104815. [PMID: 31494102 DOI: 10.1016/j.chemphyslip.2019.104815] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2019] [Revised: 08/20/2019] [Accepted: 09/01/2019] [Indexed: 10/26/2022]
Abstract
Dietary fats are present in the diet under different types of structures, such as spread vs emulsions (notably in processed foods and enteral formula), and interest is growing regarding their digestion and intestinal absorption. In clinical trials, there is often a need to add stable isotope-labeled triacylglycerols (TAGs) as tracers to the ingested fat in order to track its intestinal absorption and further metabolic fate. Because most TAG tracers contain saturated fatty acids, they may modify the physicochemical properties of the ingested labeled fat and thereby its digestion. However, the actual impact of tracer addition on fat crystalline properties and lipolysis by digestive lipases still deserves to be explored. In this context, we monitored the thermal and polymorphic behavior of anhydrous milk fat (AMF) enriched in homogeneous TAGs tracers and further compared it with the native AMF using differential scanning calorimetry and power X-ray diffraction. As tracers, we used a mixture of tripalmitin, triolein and tricaprylin at 2 different concentrations (1.5 and 5.7 wt%, which have been used in clinical trials). The addition of TAG tracers modified the AMF melting profile, especially at the highest tested concentration (5.7 wt%). Both AMF and AMF enriched with 1.5 wt% tracers were completely melted around 37 °C, i.e. close to the body temperature, while the AMF enriched with 5.7 wt% tracers remained partially crystallized at this temperature. Similar trends were observed in both bulk and emulsified systems. Moreover, the kinetics of AMF polymorphic transformation was modified in the presence of tracers. While only β' form was observed in the native AMF, the β-form was clearly detected in the AMF containing 5.7 wt% tracers. We further tested the impact of tracers on the lipolysis of AMF in bulk using a static in vitro model of duodenal digestion. Lipolysis of AMF enriched with 5.7 wt% tracers was delayed compared with that of AMF and AMF enriched with 1.5 wt% tracers. Therefore, low amounts of TAG tracers including tripalmitin do not have a high impact on fat digestion, but one has to be cautious when using higher amounts of these tracers.
Collapse
Affiliation(s)
- Sabine Danthine
- Science des Aliments et Formulation, Gembloux Agro-Bio Tech, ULiège, Gembloux, Belgium
| | - Cécile Vors
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France; Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH), Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France
| | - Damien Agopian
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France
| | - Annie Durand
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France
| | - Romain Guyon
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France
| | - Frédéric Carriere
- Aix Marseille Université, CNRS, Bioénergétique et Ingénierie des Protéines UMR7281, Marseille, France
| | - Carole Knibbe
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France; Inria "Beagle" team, Antenne Lyon la Doua, F-69603, Villeurbanne, France
| | - Marion Létisse
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France
| | - Marie-Caroline Michalski
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, INSA-Lyon, Université Claude Bernard Lyon 1, F-69621 Villeurbanne, France; Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH), Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France.
| |
Collapse
|
25
|
Picart T, Dumot C, Ducray F, Durand A, Guyotat J, Berhouma M, Meyronet D. OS8.4 Impact of brain invasion assessment on outcome in intracranial grade II meningiomas. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz126.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
BACKGROUND
Brain invasion has already been identified as an independent criterion of meningioma recurrence by Jääskaläinen’s in 1986. While it was only suggested that meningiomas harbouring brain invasion could be staged as grade II in the 2007 WHO Classification of Tumours of the Central Nervous System, brain invasion was clearly listed as a grade II atypical meningioma criterion for the first time in the 2016 version. Since 2007, brain invasion has been carefully screened during the histopathological characterisation of meningiomas in our centre thanks to specific training of the neuropathology department staff. Furthermore, neurosurgeons are asked to provide well-preserved and grossly orientable tumours borders whenever possible. The aim of the present study was to compare the characteristics of patients diagnosed with grade II meningiomas before and after this change of practices.
MATERIAL AND METHODS
We retrospectively reviewed the characteristics of 125 patients with grade II meningiomas diagnosed between 2011 and 2014 (group A) and compared them to those of 166 patients with grade II meningiomas diagnosed between 1998 and 2005 (group B).
RESULTS
Tumour location and socio-demographic parameters were comparable in group A and B with a median age of 62 years in both groups (p=0.18). There were more de novo meningiomas in group A (84% vs 68.7%, p=0.004). Brain invasion was found in 59% in group A and 9% in group B (p=0.00001) while median Ki67 labelling was of 8.4% in group A and 10.5% in group B (p=0.04). Consistently, tumour borders were irregular in 52% in group A and 29% in group B (p=0.0002). Progression free survival was similar in the two groups (65 vs 66 months, p=0.92) but grade progression was more frequently observed in group B (18.9% vs 0%, p=0.006). In group A, meningiomas that were classified as grade II exclusively based on brain infiltration (n=33, group A-bi) had a similar progression rate compared to meningiomas with other criteria of atypia (27% vs 25%, p=0.98) and a similar time to progression (32 vs 32 months, p=0.74). The median time to progression of group A-bi meningiomas was also comparable to that of the other 258 pooled meningiomas (32 vs 40 months, p=0.40).
CONCLUSION
In accordance with the 2016 WHO Classification of Tumours of the Central Nervous System, the outcome of meningiomas defined as atypical solely based on brain infiltration seems to be comparable to that of meningiomas with other criteria of atypia. Appropriate coordination between neurosurgeons and neuropathologists is mandatory to optimally assess this criterion.
Collapse
Affiliation(s)
- T Picart
- Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron, France
| | - C Dumot
- Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron, France
| | - F Ducray
- Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron, France
| | - A Durand
- Médipôle, Lyon-Villeurbanne, France
| | - J Guyotat
- Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron, France
| | - M Berhouma
- Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron, France
| | - D Meyronet
- Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron, France
| |
Collapse
|
26
|
Milard M, Penhoat A, Durand A, Buisson C, Loizon E, Meugnier E, Bertrand K, Joffre F, Cheillan D, Garnier L, Viel S, Laugerette F, Michalski MC. Acute effects of milk polar lipids on intestinal tight junction expression: towards an impact of sphingomyelin through the regulation of IL-8 secretion? J Nutr Biochem 2019; 65:128-138. [DOI: 10.1016/j.jnutbio.2018.12.007] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Revised: 10/30/2018] [Accepted: 12/12/2018] [Indexed: 02/07/2023]
|
27
|
Milard M, Laugerette F, Durand A, Buisson C, Meugnier E, Loizon E, Louche-Pelissier C, Sauvinet V, Garnier L, Viel S, Bertrand K, Joffre F, Cheillan D, Humbert L, Rainteau D, Plaisancié P, Bindels LB, Neyrinck AM, Delzenne NM, Michalski MC. Front cover: Milk Polar Lipids in a High-Fat Diet Can Prevent Body Weight Gain: Modulated Abundance of Gut Bacteria in Relation with Fecal Loss of Specific Fatty Acids. Mol Nutr Food Res 2019. [DOI: 10.1002/mnfr.201970010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
28
|
Milard M, Laugerette F, Durand A, Buisson C, Meugnier E, Loizon E, Louche-Pelissier C, Sauvinet V, Garnier L, Viel S, Bertrand K, Joffre F, Cheillan D, Humbert L, Rainteau D, Plaisancié P, Bindels LB, Neyrinck AM, Delzenne NM, Michalski MC. Milk Polar Lipids in a High-Fat Diet Can Prevent Body Weight Gain: Modulated Abundance of Gut Bacteria in Relation with Fecal Loss of Specific Fatty Acids. Mol Nutr Food Res 2019; 63:e1801078. [DOI: 10.1002/mnfr.201801078] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2018] [Revised: 12/18/2018] [Indexed: 01/14/2023]
Affiliation(s)
- Marine Milard
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Fabienne Laugerette
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Annie Durand
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Charline Buisson
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Emmanuelle Meugnier
- Univ Lyon; CarMeN Laboratory; INSERM; INRA; INSA Lyon; Université Claude Bernard Lyon 1; 69600 Oullins France
| | - Emmanuelle Loizon
- Univ Lyon; CarMeN Laboratory; INSERM; INRA; INSA Lyon; Université Claude Bernard Lyon 1; 69600 Oullins France
| | - Corinne Louche-Pelissier
- Centre de Recherche en Nutrition Humaine (CRNH) Rhône-Alpes; Centre Européen Pour la Nutrition et la Santé; Centre Hospitalier Lyon Sud; Université Claude Bernard Lyon 1; INSERM, Hospices Civils de Lyon F-69310 Pierre Bénite France
| | - Valérie Sauvinet
- Centre de Recherche en Nutrition Humaine (CRNH) Rhône-Alpes; Centre Européen Pour la Nutrition et la Santé; Centre Hospitalier Lyon Sud; Université Claude Bernard Lyon 1; INSERM, Hospices Civils de Lyon F-69310 Pierre Bénite France
| | - Lorna Garnier
- Laboratoire d'Immunologie; Hospices Civils de Lyon; Centre Hospitalier Lyon Sud; Pierre-Bénite France
| | - Sébastien Viel
- Laboratoire d'Immunologie; Hospices Civils de Lyon; Centre Hospitalier Lyon Sud; Pierre-Bénite France
| | | | | | - David Cheillan
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
- Service Biochimie et Biologie Moléculaire Grand Est; Centre de Biologie Est; Hospices Civils de Lyon; Lyon France
| | - Lydie Humbert
- Sorbonne Universités; UPMC Univ. Paris 06; École normale supérieure; PSL Research University; CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), 27 rue de Chaligny Paris 75005 France
| | - Dominique Rainteau
- Sorbonne Universités; UPMC Univ. Paris 06; École normale supérieure; PSL Research University; CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), 27 rue de Chaligny Paris 75005 France
| | - Pascale Plaisancié
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| | - Laure B. Bindels
- Louvain Drug Research Institute; Metabolism and Nutrition Research Group; Université catholique de Louvain; Brussels Belgium
| | - Audrey M. Neyrinck
- Louvain Drug Research Institute; Metabolism and Nutrition Research Group; Université catholique de Louvain; Brussels Belgium
| | - Nathalie M. Delzenne
- Louvain Drug Research Institute; Metabolism and Nutrition Research Group; Université catholique de Louvain; Brussels Belgium
| | - Marie-Caroline Michalski
- Univ Lyon; CarMeN Laboratory; INSERM U1060; INRA U1397; INSA Lyon; Université Claude Bernard Lyon 1; 69621 Villeurbanne France
| |
Collapse
|
29
|
Milard M, Laugerette F, Bugeat S, Plaisancié P, Létisse M, Meugnier E, Loizon E, Durand A, Buisson C, Géloën A, Serieye S, Michalski MC. Metabolic effects in mice of cream formulation: Addition of both thickener and emulsifier does not alter lipid metabolism but modulates mucus cells and intestinal endoplasmic reticulum stress. J Dairy Sci 2018; 101:10649-10663. [PMID: 30316592 DOI: 10.3168/jds.2018-14783] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Accepted: 08/21/2018] [Indexed: 12/19/2022]
Abstract
Additives stabilize or improve the organoleptic or functional properties (or both) of many dairy products including whipping cream. Their influence on the metabolic effect of dairy cream is scarcely known. We tested the hypothesis that added emulsifier (lactic acid esters of mono- and diglycerides; MAG/DAG), thickener (carrageenan, CGN), or both, could modify the metabolic effect, notably in the intestine and liver. Nine-week-old male C57Bl/6J mice were fed UHT cream (indirect treatment) mixed with nonlipidic powder (final: 13% milkfat) for 1 or 4 wk. We compared creams (1) without additive (Ctl), (2) with thickener (Th), 0.02% of κ-CGN, and (3) with both thickener and emulsifier, 0.1% of MAG/DAG esters (Th/Em). We analyzed plasma parameters, intestine, and liver. Fasting glycemia, insulinemia, triglyceridemia, nonesterified fatty acids, body weight gain, and liver weight did not differ among groups. After 1 wk, Th/Em had higher expression in the duodenum of some of the genes involved in (1) intestinal lipid absorption and (2) tight junction proteins versus Ctl and Th. After 4 wk, mucus cell number in the small intestine was higher in Th/Em versus Ctl and Th. Genes involved in endoplasmic reticulum (ER) stress in the duodenum were more expressed in Th/Em after 1 wk. After 4 wk, in the colon, a higher expression of ER stress genes was observed for Th versus Th/Em and Ctl. Liver damage score was not altered by additives. Adding both CGN (0.02%) and MAG/DAG esters (0.1%) in dairy cream did not result in deleterious outcomes in mice after 4 wk regarding lipid metabolism, intestinal permeability, and liver disorders. The longer term effect of intestinal ER stress modulation deserves further investigation.
Collapse
Affiliation(s)
- M Milard
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - F Laugerette
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Bugeat
- Sodiaal International Research and Innovation Department, Paris, France
| | - P Plaisancié
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - M Létisse
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - E Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - E Loizon
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - A Durand
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - C Buisson
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - A Géloën
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Serieye
- Sodiaal International Research and Innovation Department, Paris, France
| | - M-C Michalski
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France.
| |
Collapse
|
30
|
Milard M, Laugerette F, Bugeat S, Plaisancié P, Létisse M, Meugnier E, Loizon E, Durand A, Buisson C, Géloën A, Serieye S, Michalski MC. Metabolic effects in mice of cream processing: Direct ultra-high-temperature process lowers high-fat-induced adipose tissue inflammation. J Dairy Sci 2018; 101:10636-10648. [PMID: 30316591 DOI: 10.3168/jds.2018-14782] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Accepted: 08/21/2018] [Indexed: 01/12/2023]
Abstract
Although UHT heat treatment is being optimized to improve the stability and functional properties of dairy products, its metabolic effects remain scarcely known. As such, we studied the effect of the type of UHT process on lipid metabolism, intestinal barrier, and inflammation in mice. Nine-week-old male C57Bl/6J mice were fed a diet composed of nonlipidic powder mixed with different UHT dairy creams (final: 13% milkfat) for 1 or 4 wk. All creams contained 0.02% of thickener (carrageenan) and were treated via either (1) classical indirect heating process (Th), (2) indirect process at higher temperature (Th+), or (3) direct process by steam injection (ThD). Plasma, epididymal adipose tissue (EAT), and intestine were analyzed. Multivariate principal component analyses were used to identify differential effects of processes. Th+ differed by a globally higher liver damage score compared with that of the other creams. After 4 wk, the duodenal expression of lipid absorption genes fatty acid binding protein 4 (Fatp4) and microsomal triglycerides transfer protein (Mttp) was lower in the Th+ versus Th group. Expression in the colon of tight junction protein zonula occludens 1 (Zo1) and of some endoplasmic reticulum stress markers was lower in both Th+ and ThD versus the Th group. In EAT, ThD had lower gene expression of several inflammatory markers after 4 wk. Some differential effects may be related to heat-induced physicochemical changes of creams. The type of cream UHT process differentially affected metabolic parameters in mice after a 4-wk fat-rich diet, partly due to cream structure. Altogether, direct steam injection process induced the lowest early markers of high-fat-induced metabolic inflammation in EAT.
Collapse
Affiliation(s)
- M Milard
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - F Laugerette
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Bugeat
- Sodiaal International Research and Innovation Department, Paris, France
| | - P Plaisancié
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - M Létisse
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - E Meugnier
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - E Loizon
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69600 Oullins, France
| | - A Durand
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - C Buisson
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - A Géloën
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France
| | - S Serieye
- Sodiaal International Research and Innovation Department, Paris, France
| | - M-C Michalski
- Univ Lyon, CarMeN Laboratory, INSERM, INRA, Université Claude Bernard Lyon-1, INSA Lyon, 69621 Villeurbanne, France.
| |
Collapse
|
31
|
Pomares G, Duysens C, Camps C, Durand A, Falcone A, Jager T. About the article: Abi-Chahla M.-L., Alet J.-M., Fabre T., Pelissier P. Fig. 1. Treatment of defects in the tip and palmar surface of the fingers. Hand Surg Rehabil 2018;37:4-11. Hand Surg Rehabil 2018; 37:S2468-1229(18)30059-8. [PMID: 29773461 DOI: 10.1016/j.hansur.2018.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/16/2018] [Revised: 04/16/2018] [Accepted: 04/18/2018] [Indexed: 06/08/2023]
Affiliation(s)
- G Pomares
- Institut européen de la main, hôpital Kirchberg, 9, rue Edward-Steichen, 2540 Luxembourg City, Luxembourg.
| | - C Duysens
- Institut européen de la main, hôpital Kirchberg, 9, rue Edward-Steichen, 2540 Luxembourg City, Luxembourg
| | - C Camps
- Institut européen de la main, hôpital Kirchberg, 9, rue Edward-Steichen, 2540 Luxembourg City, Luxembourg; Institut européen de la main, Médipôle Gentilly, 13, rue Blaise-Pascal, 54320 Maxéville, France
| | - A Durand
- Institut européen de la main, hôpital Kirchberg, 9, rue Edward-Steichen, 2540 Luxembourg City, Luxembourg
| | - A Falcone
- Institut européen de la main, hôpital Kirchberg, 9, rue Edward-Steichen, 2540 Luxembourg City, Luxembourg; Institut européen de la main, Médipôle Gentilly, 13, rue Blaise-Pascal, 54320 Maxéville, France
| | - T Jager
- Institut européen de la main, hôpital Kirchberg, 9, rue Edward-Steichen, 2540 Luxembourg City, Luxembourg
| |
Collapse
|
32
|
Charpentier P, Brun C, Devaux E, Durand A, Roditis T, les membres du groupe Cotrim SSR de l’. Quelle prise en charge de rééducation en hospitalisation de jour dans les établissements SSR franciliens ? Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.01.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
33
|
|
34
|
Lecomte M, Couëdelo L, Meugnier E, Loizon E, Plaisancié P, Durand A, Géloën A, Joffre F, Vaysse C, Michalski MC, Laugerette F. Soybean polar lipids differently impact adipose tissue inflammation and the endotoxin transporters LBP and sCD14 in flaxseed vs. palm oil-rich diets. J Nutr Biochem 2017; 43:116-124. [PMID: 28284063 DOI: 10.1016/j.jnutbio.2017.02.004] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2016] [Revised: 01/06/2017] [Accepted: 02/08/2017] [Indexed: 01/09/2023]
Abstract
Obesity and type 2 diabetes are nutritional pathologies, characterized by a subclinical inflammatory state. Endotoxins are now well recognized as an important factor implicated in the onset and maintain of this inflammatory state during fat digestion in high-fat diet. As a preventive strategy, lipid formulation could be optimized to limit these phenomena, notably regarding fatty acid profile and PL emulsifier content. Little is known about soybean polar lipid (SPL) consumption associated to oils rich in saturated FA vs. anti-inflammatory omega-3 FA such as α-linolenic acid on inflammation and metabolic endotoxemia. We then investigated in mice the effect of different synthetic diets enriched with two different oils, palm oil or flaxseed oil and containing or devoid of SPL on adipose tissue inflammation and endotoxin receptors. In both groups containing SPL, adipose tissue (WAT) increased compared with groups devoid of SPL and an induction of MCP-1 and LBP was observed in WAT. However, only the high-fat diet in which flaxseed oil was associated with SPL resulted in both higher WAT inflammation and higher circulating sCD14 in plasma. In conclusion, we have demonstrated that LPS transporters LBP and sCD14 and adipose tissue inflammation can be modulated by SPL in high fat diets differing in oil composition. Notably high-flaxseed oil diet exerts a beneficial metabolic impact, however blunted by PL addition. Our study suggests that nutritional strategies can be envisaged by optimizing dietary lipid sources in manufactured products, including fats/oils and polar lipid emulsifiers, in order to limit the inflammatory impact of palatable foods.
Collapse
Affiliation(s)
- Manon Lecomte
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Leslie Couëdelo
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - Emmanuelle Meugnier
- INRA UMR1397, CarMeN laboratory, Univ-Lyon, INSERM U1060, Université Claude Bernard Lyon 1, F-69921 Oullins, France
| | - Emmanuelle Loizon
- INRA UMR1397, CarMeN laboratory, Univ-Lyon, INSERM U1060, Université Claude Bernard Lyon 1, F-69921 Oullins, France
| | - Pascale Plaisancié
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Annie Durand
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Alain Géloën
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Florent Joffre
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - Carole Vaysse
- ITERG-ENMS, Université de Bordeaux, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - Marie-Caroline Michalski
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France
| | - Fabienne Laugerette
- Univ-Lyon, CarMeN laboratory, INRA UMR1397, INSERM U1060, Université Claude Bernard Lyon 1, INSA-Lyon, IMBL, F-69621 Villeurbanne, France.
| |
Collapse
|
35
|
Typhaine P, Dompnier M, Vazquez R, Guerrault-Moro MN, Durand A. Réalisation d’un audit sur le circuit de la nutrition parentérale : de la prescription à l’administration. NUTR CLIN METAB 2017. [DOI: 10.1016/j.nupar.2016.10.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
36
|
Camps C, Durand A, Merle M. Traitement des fractures articulaires partielles de l’extrémité distale du radius du sujet jeune actif. Hand Surgery and Rehabilitation 2016; 35S:S126-S132. [DOI: 10.1016/j.hansur.2016.07.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/30/2015] [Revised: 02/29/2016] [Accepted: 07/12/2016] [Indexed: 11/16/2022]
|
37
|
Durand A, Camps C, Merle M. Traitement des cals vicieux articulaires de l’extrémité distale du radius du sujet jeune actif. Hand Surgery and Rehabilitation 2016; 35S:S105-S111. [DOI: 10.1016/j.hansur.2016.03.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2015] [Revised: 02/07/2016] [Accepted: 03/04/2016] [Indexed: 11/16/2022]
|
38
|
Païta L, Al-Mawla R, Bidault-Ducreux S, Chouabe C, Durand A, Augeul L, Dupré-Aucouturier S, Bonvallet R, Ovize M, Van Coppenolle F. 0215 : Is Transient Receptor Potential Vanilloid Type 1 (TRPV1) a target of isoflurane in cardiomyocytes? Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30419-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
|
40
|
Rieusset J, Fauconnier J, Paillard M, Belaidi E, Tubbs E, Chauvin MA, Durand A, Bravard A, Teixeira G, Bartosch B, Michelet M, Theurey P, Vial G, Demion M, Blond E, Zoulim F, Gomez L, Vidal H, Lacampagne A, Ovize M. Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance. Diabetologia 2016; 59:614-23. [PMID: 26660890 DOI: 10.1007/s00125-015-3829-8] [Citation(s) in RCA: 107] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2015] [Accepted: 11/17/2015] [Indexed: 12/24/2022]
Abstract
AIMS/HYPOTHESIS Mitochondria-associated endoplasmic reticulum membranes (MAMs) are regions of the endoplasmic reticulum (ER) tethered to mitochondria and controlling calcium (Ca(2+)) transfer between both organelles through the complex formed between the voltage-dependent anion channel, glucose-regulated protein 75 and inositol 1,4,5-triphosphate receptor (IP3R). We recently identified cyclophilin D (CYPD) as a new partner of this complex and demonstrated a new role for MAMs in the control of insulin's action in the liver. Here, we report on the mechanisms by which disruption of MAM integrity induces hepatic insulin resistance in CypD (also known as Ppif)-knockout (KO) mice. METHODS We used either in vitro pharmacological and genetic inhibition of CYPD in HuH7 cells or in vivo loss of CYPD in mice to investigate ER-mitochondria interactions, inter-organelle Ca(2+) exchange, organelle homeostasis and insulin action. RESULTS Pharmacological and genetic inhibition of CYPD concomitantly reduced ER-mitochondria interactions, inhibited inter-organelle Ca(2+) exchange, induced ER stress and altered insulin signalling in HuH7 cells. In addition, histamine-stimulated Ca(2+) transfer from ER to mitochondria was blunted in isolated hepatocytes of CypD-KO mice and this was associated with an increase in ER calcium store. Interestingly, disruption of inter-organelle Ca(2+) transfer was associated with ER stress, mitochondrial dysfunction, lipid accumulation, activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)ε and insulin resistance in liver of CypD-KO mice. Finally, CYPD-related alterations of insulin signalling were mediated by activation of PKCε rather than JNK in HuH7 cells. CONCLUSIONS/INTERPRETATION Disruption of IP3R-mediated Ca(2+) signalling in the liver of CypD-KO mice leads to hepatic insulin resistance through disruption of organelle interaction and function, increase in lipid accumulation and activation of PKCε. Modulation of ER-mitochondria Ca(2+) exchange may thus provide an exciting new avenue for treating hepatic insulin resistance.
Collapse
Affiliation(s)
- Jennifer Rieusset
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France.
| | - Jeremy Fauconnier
- Inserm U1046-CNRS UMR-9214, PhyMedExp, Université Montpellier, Montpellier, France
| | - Melanie Paillard
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Elise Belaidi
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Emily Tubbs
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Marie-Agnès Chauvin
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Annie Durand
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Amélie Bravard
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Geoffrey Teixeira
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Birke Bartosch
- Inserm UMR-1052, Centre de recherche en Cancérologie de Lyon, Université Lyon 1, Lyon, France
| | - Maud Michelet
- Inserm UMR-1052, Centre de recherche en Cancérologie de Lyon, Université Lyon 1, Lyon, France
| | - Pierre Theurey
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Guillaume Vial
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Marie Demion
- Inserm U1046-CNRS UMR-9214, PhyMedExp, Université Montpellier, Montpellier, France
| | - Emilie Blond
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
- Hospices Civils de Lyon, Lyon, France
| | - Fabien Zoulim
- Inserm UMR-1052, Centre de recherche en Cancérologie de Lyon, Université Lyon 1, Lyon, France
- Hospices Civils de Lyon, Lyon, France
| | - Ludovic Gomez
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Hubert Vidal
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
| | - Alain Lacampagne
- Inserm U1046-CNRS UMR-9214, PhyMedExp, Université Montpellier, Montpellier, France
| | - Michel Ovize
- Inserm UMR-1060, Laboratoire CarMeN, Université Lyon 1, 165 chemin du grand Revoyet, BP12, 69921, Oullins cedex, France
- Hospices Civils de Lyon, Lyon, France
| |
Collapse
|
41
|
Lecomte M, Couëdelo L, Meugnier E, Plaisancié P, Létisse M, Benoit B, Gabert L, Penhoat A, Durand A, Pineau G, Joffre F, Géloën A, Vaysse C, Laugerette F, Michalski MC. Dietary emulsifiers from milk and soybean differently impact adiposity and inflammation in association with modulation of colonic goblet cells in high-fat fed mice. Mol Nutr Food Res 2016; 60:609-20. [PMID: 26592505 DOI: 10.1002/mnfr.201500703] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Revised: 11/04/2015] [Accepted: 11/09/2015] [Indexed: 12/12/2022]
Abstract
SCOPE Enhanced adiposity and metabolic inflammation are major features of obesity that could be impacted by dietary emulsifiers. We investigated in high-fat fed mice the effects of using a new polar lipid (PL) emulsifier from milk (MPL) instead of soybean lecithin (soybean PL [SPL]) on adipose tissue and intestinal mucosa function. METHODS AND RESULTS Four groups of C57BL6 mice received for 8 wks a low-fat (LF) diet or a high-fat diet devoid of PLs or an high-fat diet including MPL (high-fat-MPL) or SPL (high-fat-SPL). Compared with high-fat diet, high-fat-SPL diet increased white adipose tissue (WAT) mass (p < 0.05), with larger adipocytes (p < 0.05) and increased expression of tumor necrosis factor alpha, monochemoattractant protein-1, LPS-binding protein, and leptin (p < 0.05). This was not observed with high-fat-MPL diet despite similar dietary intakes and increased expression of fatty acid transport protein 4 and microsomal TG transfer protein, involved in lipid absorption, in upper intestine (p < 0.05). High-fat-MPL mice had a lower expression in WAT of cluster of differentiation 68, marker of macrophage infiltration, versus high-fat and high-fat-SPL mice (p < 0.05), and more goblet cells in the colon (p < 0.05). CONCLUSIONS Unlike SPL, MPL in the high-fat diet did not induce WAT hypertrophy and inflammation but increased colonic goblet cells. This supports further clinical exploration of different sources of dietary emulsifiers in the frame of obesity outbreak.
Collapse
Affiliation(s)
- Manon Lecomte
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | | | | | - Pascale Plaisancié
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Marion Létisse
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Bérengère Benoit
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Laure Gabert
- INSERM U1060, INRA UMR1397, CarMeN Laboratory, Oullins, France
- Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) and Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France
| | - Armelle Penhoat
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Annie Durand
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Gaëlle Pineau
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | | | - Alain Géloën
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | | | - Fabienne Laugerette
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
| | - Marie-Caroline Michalski
- INRA, UMR1397, INSERM U1060, CarMeN Laboratory, INSA-Lyon, IMBL, Université Lyon 1, Villeurbanne, France
- Centre de Recherche en Nutrition Humaine Rhône-Alpes (CRNH-RA) and Centre Européen pour la Nutrition et la Santé (CENS), Pierre-Bénite, France
| |
Collapse
|
42
|
Davoine C, Guibert A, Marchand X, Durand A. OHP-013 Coronary stents in a regional hospital: Evolution and analysis from 2011 to 2015. Eur J Hosp Pharm 2016. [DOI: 10.1136/ejhpharm-2016-000875.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
43
|
Durand A, Penchet G, Thines L. Intraoperative monitoring by imaging and electrophysiological techniques during giant intracranial aneurysm surgery. Neurochirurgie 2016; 62:14-9. [DOI: 10.1016/j.neuchi.2015.03.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2014] [Revised: 02/05/2015] [Accepted: 03/01/2015] [Indexed: 12/30/2022]
|
44
|
Gomez L, Thiebaut PA, Paillard M, Ducreux S, Abrial M, Crola Da Silva C, Durand A, Alam MR, Van Coppenolle F, Sheu SS, Ovize M. The SR/ER-mitochondria calcium crosstalk is regulated by GSK3β during reperfusion injury. Cell Death Differ 2016; 22:1890. [PMID: 26434983 DOI: 10.1038/cdd.2015.118] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
45
|
Durand A, Finck M, Sullivan M, Hammond G. Computed tomography and magnetic resonance diagnosis of variations in the anatomical location of the major salivary glands in 1680 dogs and 187 cats. Vet J 2015; 209:156-62. [PMID: 26832809 DOI: 10.1016/j.tvjl.2015.07.017] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2015] [Revised: 07/13/2015] [Accepted: 07/17/2015] [Indexed: 11/18/2022]
Abstract
During assessment of routine clinical magnetic resonance imaging (MRI) of the heads of dogs, variations in the location of mandibular and zygomatic salivary glands (SGs) were observed incidentally. The aims of this retrospective study were to describe anatomical variations of the major SGs found on MRI and computed tomography (CT) studies of the head in dogs and cats and to investigate possible clinical relevancy. No anatomical variation of the SGs was seen in cats, but in dogs, although variation of the parotid SG was not identified, that of the mandibular SG was found in 33/1680 animals (2%), either unilaterally (6/33 right-sided, 13/33 left-sided) or bilaterally (14/33). The Border terrier breed (19/33, 58%) was over-represented. Each atypically located mandibular SG was positioned medial to the digastric muscle and rostral to the retropharyngeal lymph node. The sublingual glands were difficult to delineate from the mandibular glands. Anatomical variation of one zygomatic gland (3/4 left-sided) was identified in four small-breed dogs (0.2%). Each atypically located zygomatic gland was tilted at the ventrorostral aspect of the masseter muscle underneath the skin surface. MRI and CT characteristics were not different between typically and atypically located SGs. None of the dogs had clinical signs related with SG disease. It was concluded that, with suspected breed predispositions, incidental unilateral or bilateral anatomical variations of mandibular and zygomatic SGs can be encountered in dogs and an awareness of these possible variations may be important in pre-surgical planning.
Collapse
Affiliation(s)
- A Durand
- Diagnostic Imaging Department, Small Animal Hospital, School of Veterinary Medicine, College of Medical, Veterinary and Life Science, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK.
| | - M Finck
- Diagnostic Imaging Department, Small Animal Hospital, School of Veterinary Medicine, College of Medical, Veterinary and Life Science, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK
| | - M Sullivan
- Diagnostic Imaging Department, Small Animal Hospital, School of Veterinary Medicine, College of Medical, Veterinary and Life Science, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK
| | - G Hammond
- Diagnostic Imaging Department, Small Animal Hospital, School of Veterinary Medicine, College of Medical, Veterinary and Life Science, University of Glasgow, Bearsden Road, Glasgow G61 1QH, UK
| |
Collapse
|
46
|
Thines L, Proust F, Marinho P, Durand A, van der Zwan A, Regli L, Lejeune JP. Giant and complex aneurysms treatment with preservation of flow via bypass technique. Neurochirurgie 2015; 62:1-13. [PMID: 26072226 DOI: 10.1016/j.neuchi.2015.03.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2014] [Revised: 02/02/2015] [Accepted: 03/01/2015] [Indexed: 10/23/2022]
Abstract
Due to their anatomical characteristics and the complexity of the procedures required to obtain their complete occlusion, the treatment of giant intracranial aneurysms is a real challenge. Direct reconstructive strategies, whether by interventional neuroradiology (coils, stents) or microsurgical (clipping) means, are not always applicable and, in patients that would not tolerate parent or collateral artery sacrifice, the adjunction of a revascularization procedure using a bypass technique might be necessary. Cerebral arterial bypasses can be classified according to their function (3 types: flow replacement, flow reversal or protective), the branching mode of the graft used (3 types: pedicled, interpositional or in situ), the sites of anastomosis (2 types: extracranial-intracranial or intracranial-intracranial) and the class of flow they are supposed to provide (3 types: low-, intermediate- or high-flow). In this article, the authors review the different aspects in the management of patients with a giant intracranial aneurysm using a bypass: preoperative work-up, types of bypass and indications, surgical techniques and results.
Collapse
Affiliation(s)
- L Thines
- Clinique de neurochirurgie, Pôle des neurosciences et appareil locomoteur, CHRU de Lille, Université Lille Nord de France, 59000 Lille, France.
| | - F Proust
- Service de neurochirurgie, Hôpital Charles-Nicolle, CHU de Rouen, 76038 Rouen, France
| | - P Marinho
- Clinique de neurochirurgie, Pôle des neurosciences et appareil locomoteur, CHRU de Lille, Université Lille Nord de France, 59000 Lille, France
| | - A Durand
- Clinique du Tonkin, 69626 Villeurbanne cedex, France
| | - A van der Zwan
- Department of Neurosurgery, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
| | - L Regli
- Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland
| | - J-P Lejeune
- Clinique de neurochirurgie, Pôle des neurosciences et appareil locomoteur, CHRU de Lille, Université Lille Nord de France, 59000 Lille, France
| |
Collapse
|
47
|
Vial G, Chauvin MA, Bendridi N, Durand A, Meugnier E, Madec AM, Bernoud-Hubac N, Pais de Barros JP, Fontaine É, Acquaviva C, Hallakou-Bozec S, Bolze S, Vidal H, Rieusset J. Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model. Diabetes 2015; 64:2254-64. [PMID: 25552598 DOI: 10.2337/db14-1220] [Citation(s) in RCA: 101] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2014] [Accepted: 12/20/2014] [Indexed: 12/13/2022]
Abstract
Imeglimin is the first in a new class of oral glucose-lowering agents currently in phase 2b development. Although imeglimin improves insulin sensitivity in humans, the molecular mechanisms are unknown. This study used a model of 16-week high-fat, high-sucrose diet (HFHSD) mice to characterize its antidiabetic effects. Six-week imeglimin treatment significantly decreased glycemia, restored normal glucose tolerance, and improved insulin sensitivity without modifying organs, body weights, and food intake. This was associated with an increase in insulin-stimulated protein kinase B phosphorylation in the liver and muscle. In liver mitochondria, imeglimin redirects substrate flows in favor of complex II, as illustrated by increased respiration with succinate and by the restoration of respiration with glutamate/malate back to control levels. In addition, imeglimin inhibits complex I and restores complex III activities, suggesting an increase in fatty acid oxidation, which is supported by an increase in hepatic 3-hydroxyacetyl-CoA dehydrogenase activity and acylcarnitine profile and the reduction of liver steatosis. Imeglimin also reduces reactive oxygen species production and increases mitochondrial DNA. Finally, imeglimin effects on mitochondrial phospholipid composition could participate in the benefit of imeglimin on mitochondrial function. In conclusion, imeglimin normalizes glucose tolerance and insulin sensitivity by preserving mitochondrial function from oxidative stress and favoring lipid oxidation in liver of HFHSD mice.
Collapse
Affiliation(s)
- Guillaume Vial
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France Center for European Nutrition and Health, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
| | | | - Nadia Bendridi
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France
| | - Annie Durand
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France
| | | | | | | | - Jean-Paul Pais de Barros
- Plateforme de lipidomique, Université de Bourgogne, Centre Hospitalier Universitaire le Bocage, Dijon, France
| | - Éric Fontaine
- INSERM U1055, Laboratoire de Bioénergétique Fondamentale et Appliquée (LBFA) et SFR Biologie Environnementale et Systémique (BEeSy), Grenoble, France Joseph Fourier University, Grenoble, France Grenoble University Hospital, Grenoble, France
| | - Cécile Acquaviva
- Service Maladies Héréditaires du Métabolisme, Centre de Biologie et Pathologie Est, Centre Hospitalier Universitaire de Lyon et UMR, Bron, France
| | | | | | - Hubert Vidal
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France Center for European Nutrition and Health, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France Endocrinology, Diabetology, and Nutrition Service, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France
| | - Jennifer Rieusset
- INSERM U1060, Faculté de Médecine Lyon-Sud, Oullins, France Center for European Nutrition and Health, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France Endocrinology, Diabetology, and Nutrition Service, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite, France
| |
Collapse
|
48
|
Finck M, Durand A, Hammond G, Sullivan M, King A. Evaluation of the ventro 20° rostral-dorsocaudal oblique radiographic projection for the investigation of canine nasal disease. J Small Anim Pract 2015; 56:491-8. [PMID: 26011670 DOI: 10.1111/jsap.12369] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2014] [Revised: 03/20/2015] [Accepted: 04/15/2015] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To assess the ventro 20° rostral-dorsocaudal oblique projection for canine nasal disease as an alternative to the dorsoventral intra-oral view. MATERIALS AND METHODS Thirty-one dogs with nasal disease underwent radiography and computed tomography with a final diagnosis of underlying cause achieved through rhinoscopy, biopsy or cytology. Three independent observers, blinded to diagnosis, reviewed the nasal radiographs on two separate occasions. Intra- and inter-observer agreement and level of confidence on radiographic diagnosis were evaluated and radiographic diagnosis was compared with computed tomography and definitive diagnosis. RESULTS The ventro 20° rostral-dorsocaudal oblique projection of canine nasal cavities was feasible in anaesthetised dogs and gave diagnostic quality images in most dogs. Assessment of this view showed moderate to substantial agreement with computed tomography diagnosis but gave lower confidence in diagnosis. Interpretation of this radiographic projection had substantial to almost perfect repeatability but moderate reproducibility. CLINICAL SIGNIFICANCE The ventro 20° rostral-dorsocaudal oblique projection may be used as a valuable initial screening tool for canine nasal pathology in practices without access to advanced imaging, although computed tomography is still likely to provide greater diagnostic information.
Collapse
Affiliation(s)
- M Finck
- School of Veterinary Medicine, College of Medicine, Veterinary Medicine & Life Sciences, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, Scotland
| | - A Durand
- School of Veterinary Medicine, College of Medicine, Veterinary Medicine & Life Sciences, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, Scotland
| | - G Hammond
- School of Veterinary Medicine, College of Medicine, Veterinary Medicine & Life Sciences, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, Scotland
| | - M Sullivan
- School of Veterinary Medicine, College of Medicine, Veterinary Medicine & Life Sciences, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, Scotland
| | - A King
- School of Veterinary Medicine, College of Medicine, Veterinary Medicine & Life Sciences, University of Glasgow, Bearsden Road, Glasgow, G61 1QH, Scotland
| |
Collapse
|
49
|
Delespierre T, Denormandie P, Durand A, Josseran L. Comment passer d’un usage individuel du dossier résident à un bénéfice collectif avec le « Data Warehouse » Korian et bâtir une base de données de santé publique ? Rev Epidemiol Sante Publique 2015. [DOI: 10.1016/j.respe.2015.03.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
50
|
Marlu R, Barthelon J, Durand A, Mathieu N, Barro C, Granger V, Tatu A, Pernod G, Polack B, Bonaz B. Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions. Am J Gastroenterol 2015; 110:352-3. [PMID: 25646919 DOI: 10.1038/ajg.2014.391] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Raphael Marlu
- Hemostasis Unit, University Hospital, Grenoble, France
| | - J Barthelon
- Gastroenterology Unit, University Hospital, Grenoble, France
| | - A Durand
- Gastroenterology Unit, University Hospital, Grenoble, France
| | - N Mathieu
- Gastroenterology Unit, University Hospital, Grenoble, France
| | - C Barro
- Hemostasis Unit, University Hospital, Grenoble, France
| | - V Granger
- Gastroenterology Unit, University Hospital, Grenoble, France
| | - A Tatu
- Gastroenterology Unit, University Hospital, Grenoble, France
| | - G Pernod
- Vascular Medical Unit, University Hospital, Grenoble, France
| | - B Polack
- Hemostasis Unit, University Hospital, Grenoble, France
| | - B Bonaz
- Gastroenterology Unit, University Hospital, Grenoble, France
| |
Collapse
|